Position in TRVI
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$28,588,377
+$14,070,106 QoQ
Shares Held
1,532,889
+26.0% QoQ
Ownership
1.08%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#29
of 216 holders
Holding Since
Jun 2020
17 quarters on record
Voting authority
Sole 95%
Shared 0%
None 5%
Common Shares in TRVI Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026BANK OF AMERICA CORP /DE/ holds $10,050,306,032 across 338 Biotechnology names. TRVI ranks #69 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,039,178 | $1,509,650,884 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,291,053 | $805,023,185 | |
| 3 | CYTK |
Cytokinetics Inc
|
4,635,709 | $394,916,048 | |
| 4 | ARGX |
Argenx SE
|
400,234 | $371,325,094 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
994,476 | $299,367,107 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
1,136,091 | $273,763,844 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
4,568,341 | $259,527,450 | |
| 8 | RPRX |
Royalty Pharma plc
|
4,149,422 | $232,658,090 |
All Filings in TRVI
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $28,588,377 | 1,532,889 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $14,518,271 | 1,216,955 | Shares | Defined | 2026-05-18 | |
| 2025-12-31 | $13,707,533 | 1,094,851 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $16,807,075 | 1,836,839 | Shares | Defined | 2026-02-03 | |
| 2025-06-30 | $6,003,308 | 1,097,497 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $828,800 | 131,765 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $187,323 | 45,467 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $159,474 | 47,747 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $131,966 | 44,284 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $75,816 | 21,976 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $56,269 | 41,992 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $62,550 | 28,693 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $89,840 | 37,590 | Shares | Defined | 2023-08-14 | |
| 2022-12-31 | $176 | 92 | Shares | Defined | 2023-02-10 | |
| 2021-03-31 | $43 | 16 | Shares | Defined | 2021-05-14 | |
| 2020-09-30 | $721 | 179 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $263 | 40 | Shares | Defined | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||